
Keywords: ADA, anti-drug antibody; MAb, monoclonal antibody; NAb, neutralizing antibody; CLB, competitive ligand binding; MRD, minimal required dilution; PC, positive control; PHS, pooled human serum; MAb, monoclonal antibody; IC50, half of maximal inhibitory conce